DNA

BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure

SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for…

9 months ago

Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development – Oncology

Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across…

9 months ago

4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME

EMERYVILLE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology…

9 months ago

UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing…

9 months ago

CellFE® Partners with DKFZ and TcellTech to Advance DNA Vector Genetic Engineering for Cellular Therapies

ALAMEDA, Calif., April 30, 2025 /PRNewswire/ -- CellFE, a leader in non-viral gene editing technology, today announced a strategic collaboration…

9 months ago

AngelEye Health Unveils AIVision: Elevating Neonatal and Pediatric Care through AI and Computer Vision

AIVision combines advanced machine learning with bedside cameras to enable intelligent clinical insights NASHVILLE, Tenn.--(BUSINESS WIRE)--AngelEye Health proudly announces AIVision,…

9 months ago

PathAI to Present at Digestive Disease Week

BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present…

9 months ago

Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow

Kytopen and Aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies. High transgene expression and improved…

9 months ago

Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow

Kytopen and Aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies. High transgene expression and improved…

9 months ago

Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow

Kytopen and Aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies. High transgene expression and improved…

9 months ago